Gourt > Health > Conditions and Diseases > Cancer > Gastrointestinal > Liver > Childhood > Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC, also called hepatoma) is a primary malignancy (cancer) of the liver. Most cases of HCC are secondary to either hepatitis infection (usually hepatitis B or C) or cirrhosis (alcoholism being the most common cause of hepatic cirrhosis). In countries where hepatitis is not endemic, most malignant cancers in the liver are not primary HCC but metastasis (spread) of cancer from elsewhere in the body, e.g. the colon. Treatment options of HCC and prognosis are dependent on many factors but especially on tumor size and staging.
Outside of the West, the commonly accepted prognosis is a median survival of 3 months from diagnosis. This is partially due to late presentation with large tumours, but also the lack of medical expertise and facilities.
Epidemiology
The epidemiology of HCC exhibits two main patterns, one in North America and Western Europe and another in Non-Western Countries (regions such as sub-Saharan Africa, central Asia, Southeast Asia, and the Amazon basin). More on [ Hepatocellular carcinoma ]
RT @cancer_news: Hepatocellular carcinoma - http://is.gd/5Kv1z
BeetleMed (Beetle Med) Sun, 03 Jan 2010 08:14:38 -0000
RT @cancer_news: Hepatocellular carcinoma - http://is.gd/5Kv1z
[VEGF] Chitosan Nanoparticles Inhibit the Growth of Human Hepatocellular Carcinoma Xenografts through .. http://bit.ly/80uIkq PM
VEGFRSSfeeds (VEGF RSS Feeds) Sat, 02 Jan 2010 11:27:33 -0000
[VEGF] Chitosan Nanoparticles Inhibit the Growth of Human Hepatocellular Carcinoma Xenografts through .. http://bit.ly/80uIkq PM
efficacy & tolerability of abt-869 vs sorafenib in advanced hepatocellular carcinoma http://bit.ly/6mNc5O
newtrials_ (New Clinical Trials) Sat, 02 Jan 2010 10:50:17 -0000
efficacy & tolerability of abt-869 vs sorafenib in advanced hepatocellular carcinoma http://bit.ly/6mNc5O
efficacy & tolerability of abt-869 vs sorafenib in advanced hepatocellular carcinoma http://bit.ly/6mNc5O
localtrials (US Clinical Trials ) Sat, 02 Jan 2010 10:46:25 -0000
efficacy & tolerability of abt-869 vs sorafenib in advanced hepatocellular carcinoma http://bit.ly/6mNc5O
efficacy & tolerability of abt-869 vs sorafenib in advanced hepatocellular carcinoma http://bit.ly/6mNc5O
ustrials (US Trials) Sat, 02 Jan 2010 10:46:24 -0000
efficacy & tolerability of abt-869 vs sorafenib in advanced hepatocellular carcinoma http://bit.ly/6mNc5O
efficacy & tolerability of abt-869 vs sorafenib in advanced hepatocellular carcinoma http://bit.ly/6mNc5O
paidtrials (US Clinical Trials) Sat, 02 Jan 2010 10:42:27 -0000
efficacy & tolerability of abt-869 vs sorafenib in advanced hepatocellular carcinoma http://bit.ly/6mNc5O
Hepatocellular Carcinoma - Brief article about a rare cancer that arises from hepatocytes, the major cell type of the liver.
